Search results
Results from the WOW.Com Content Network
There’s no concrete answer, although one study found that women experience decreased sex drive between ages 55 and 64; another study found that as many as 40 percent of women over 60 have low ...
The Sexual Health in Older Adults Research (SHOAR) program [9] is one of the few research studies devoted to the sexual health preferences of older adults. Their overall aim was to obtain evidence for improving sexual health services among middle-aged and older adults (45 and older) and generate relevant policy recommendations for local ...
The 2009 NSSHB surveyed nearly 6,000 individuals between the age of 14 and 94, living in the United States. Findings showed a wide variety of sexual behavior. According to one of the lead investigators, Debby Herbenick, PhD, of Indiana University in Bloomington, "Adult men and women rarely engage in just one sex act when they have sex."
In one study on 515 women ages 29 to 97 who had heart attacks, shortness of breath occurred in more than 40%. There is never any harm in seeing a doctor for your peace of mind. 5.
Adolescent health creates a major global burden and has a great deal of additional and diverse complications compared to adult reproductive health such as early pregnancy and parenting issues, difficulties accessing contraception and safe abortions, lack of healthcare access, and high rates of HIV, sexually transmitted infections and mental health issues.
Estradiol seems to be the most important hormone for sexual desire in women. [49] [28] [50] [51] Periovulatory levels of estradiol increase sexual desire in postmenopausal women. [49] Based on animal research, progesterone may also be involved in sexual function in women.
Participants were given diagrams of 13 different sex acts, which participants rated on a scale of 1 to 4 in terms of sexual pleasure. (Not all of these sexual activities involved penile penetration.)
However, the risk with low-dose combined hormonal contraceptives remain relatively low in most cases. Health providers may recommend against formulations with estrogen in women with certain risk factors including personal or family history of blood clots, pregnancy and the first 3 weeks postpartum, obesity, inactivity, and coagulation disorders.